AFP and hepatocellular carcinoma: For example, the microRNA miR-21 has higher serum values in patients with HCC compared with healthy subjects, and its positive rate in the AFP-negative HCC group was 77.6%, with a sensitivity of 81.2% and specificity of 83.2% (12).